Millie
your market intelligence analyst
Search Results
87 results
Your search is now limited to «Non-Hodgkin Lymphoma» expert search.
Business Wire 11/15/2019 07:30
... 2007, REVLIMID has continued to demonstrate its benefits across a range of serious blood disorders in Europe and a CHMP positive opinion for this combination with rituximab is very good news for patients with follicular lymphoma.
More from Business Wire:
GlobeNewswire 11/14/2019 16:20
The approval of BRUKINSA as a second line therapy represents an important advancement for the treatment of mantle cell lymphoma,” said Meghan Gutierrez, Chief Executive Officer for the Lymphoma Research Foundation.
More from GlobeNewswire:
PR Newswire 11/14/2019 15:45
In relapsed lymphoma, the disease reappears or grows again after a period of remission, while in refractory lymphoma, the disease does not respond to treatment or responds only briefly.
More from PR Newswire:
ClinicalTrials.gov 11/13/2019 10:14
Condition : Non Hodgkin Lymphoma Intervention : Drug: Kymriah Sponsors : University of Cologne; Novartis Not yet recruiting.
More from ClinicalTrials.gov:
Cancer Network 11/13/2019
Overcoming resistance and determining better treatment plans that address the underlying disease biology of mantle cell lymphoma.
More from Cancer Network:
Further study with a larger sample size is needed to verify these biomarkers in predicting lymphoma CNS involvement.
More from International Journal of COPD:
BioNewsFeeds 11/08/2019 14:00
The trial is expected to enroll 900 patients with several lymphoma types, including diffuse large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, and marginal zone lymphoma.
More from BioNewsFeeds:
Onclive 11/06/2019 10:31
With a variety of available agents in follicular lymphoma, determining which treatments to choose and how best to sequence them can be challenging.
More from Onclive:
Results from a cohort of patients with follicular lymphoma (FL) will be reported separately.
More from American Society of Clinical Oncolgy (ASCO):
PubMed News (NIH) 11/01/2019
Contributors : Haiwen Ni ; Isere Kuiatse ; Fazal Shirazi ; Hua Wang ; Richard J Jones ; Zhiqiang Wang ; R E Davis ; Robert Z Orlowski Series Type : Expression profiling by array Organism : Homo sapiens. The L265P mutation in MYD88 is very frequent in tumor cells of Waldenström’s macroglobulinemia (WM), and activates NF-kappaB through IRAK1 and IRAK4.
More from PubMed News (NIH):
Targeted Oncology 10/30/2019 18:13
Umbralisib (TGR-1202) monotherapy demonstrated positive responses in patients with previously treated follicular lymphoma, meeting the primary end point for the follicular lymphoma cohort of the phase IIb UNITY-NHL trial, TG Therapeutics announced in a press release.
More from Targeted Oncology:
If approved, COPIKTRA will add to the company's already approved product list, with its first FDA approved product now available for the treatment of patients with certain types of indolent non-Hodgkin's lymphoma (iNHL.
More from Middle East North Africa Financial Network (MENAFN):

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications